Trials / Completed
CompletedNCT07368569
A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body
Investigation of the Effect of BI 764198 on the Pharmacokinetics of Metformin Following Multiple Oral Administration in Healthy Male and Female Trial Participants (an Open-label, Randomised, Two-way Crossover Trial)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin hydrochloride | Metformin hydrochloride |
| DRUG | BI 764198 | BI 764198 |
Timeline
- Start date
- 2026-02-06
- Primary completion
- 2026-03-14
- Completion
- 2026-03-17
- First posted
- 2026-01-26
- Last updated
- 2026-04-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07368569. Inclusion in this directory is not an endorsement.